Phase
Condition
N/ATreatment
Discussion Control Arm
TI-CBT Intervention Arm
Clinical Study ID
Ages 15-19 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria - For Youth Participants:
At screening, 15-19 years old.
If of legal age to provide independent informed consent as determined by site Standard Operating Procedures (SOPs) and consistent with site IRB/EC policies and procedures: potential youth participant is willing and able to provide written informed consent for study participation.
If not of legal age to provide independent informed consent: Parent or guardian is willing and able to provide written informed consent for study participation and potential youth participant is willing and able to provide written informed assent for study participation.
Confirmed HIV-infection based on documented testing of two samples collected at different time points as documented in medical records or by confirmatory testing.
At screening, aware of his or her HIV infection, as confirmed by Investigator of Record or designee.
At screening, has been prescribed ART for a minimum of 24 weeks prior to screening based on medical record documentation.
At screening, meets at least one of the following indicators of moderate to severe mental health symptomology:
Patient Health Questionnaire-9 (PHQ-9) score ≥ 10
General Anxiety Disorder-7 (GAD-7) score ≥ 10
UCLA Post-Traumatic Stress Disorder-Reaction Index (UCLA PTSD-RI) score > 35
Inclusion Criteria - For Caregiver Participants:
Caregiver, defined as a biological parent, legal guardian, or person who provides emotional, psychological and/or informational care to a youth taking part in the Randomized Trial, as identified by the youth, and for whom the youth has provided written permission to participate in the study.
Of legal age to provide independent consent and willing and able to provide written informed consent for study participation.
Exclusion Criteria - For Youth Participants:
At entry, participating in a study delivering a mental health or ART adherence intervention.
Has prior participation in an IMPAACT 2016 Focus Group or Pilot Test
Any other condition, adverse social situation or cognitive impairment that, in the opinion of the site investigator, would preclude informed assent and informed consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
Exclusion Criteria - For Caregiver Participants:
Has prior participation in an IMPAACT 2016 Focus Group or Pilot Test.
Study Design
Study Description
Connect with a study center
Gaborone Prevention/Treatment Trials CRS 12701
Gaborone,
BotswanaSite Not Available
Molepolole Prevention/Treatment Trials CRS 12702
Molepolole,
BotswanaSite Not Available
College of Medicine CRS 30301
Blantyre,
MalawiSite Not Available
University of North Carolina Lilongwe CRS 12001
Lilongwe,
MalawiSite Not Available
Soweto IMPAACT CRS 8052
Soweto,
South AfricaSite Not Available
St. Mary's CRS 30303
Chitungwiza,
ZimbabweSite Not Available
Harare Family Care CRS 31890
Harare,
ZimbabweSite Not Available
Seke North CRS 30306
Harare,
ZimbabweSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.